Goldstein rejoins SVB as biz dev head for life science and healthcare

• Goldstein first joined SVB in 2012
• Most recently, she was a managing partner SVB Capital, where she launched and led its first dedicated life sciences investment team
• Prior to joining SVB, Goldstein served as a director on Pfizer’s VC team

Silicon Valley Bank, a division of First Citizens Bank, has named Jennifer Friel Goldstein as head of business development and strategic initiatives for life science and healthcare banking.

In this role, Goldstein will identify market opportunities to connect VC and industry stakeholders to SVB’s clients and prospects.

“SVB is uniquely positioned to serve the needs of companies across Life Science and Healthcare, and we continue to invest in and strengthen our support for clients in these important sectors,” Joan Parson, head of technology and healthcare banking, said in a statement. “For more than 20 years, Jennifer has supported the life science and healthcare venture capital and start-up market and I’m confident our clients will continue to benefit from her extensive experience and expertise in both business and biotechnology. We are thrilled to welcome Jennifer back to the team.”

Goldstein first joined SVB in 2012.

Most recently, she was a managing partner with venture investing firm SVB Capital, where she launched and led its first dedicated life sciences investment team. Prior to joining SVB, Goldstein served as a director on Pfizer’s venture capital team, where she helped lead or co-lead investments into several life sciences companies and served as a management consultant at Bain & Co, focused on private equity projects across Europe.

Headquartered in Santa Clara, California, SVB provides commercial and private banking to individuals and companies in the technology, life science and healthcare, private equity, venture capital and premium wine industries.